PMC:7144273 / 52207-52533 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T838","span":{"begin":111,"end":121},"obj":"GO:0065007"},{"id":"T839","span":{"begin":264,"end":291},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T840","span":{"begin":296,"end":313},"obj":"CL:0009002"},{"id":"T29856","span":{"begin":111,"end":121},"obj":"GO:0065007"},{"id":"T38267","span":{"begin":264,"end":291},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T40683","span":{"begin":296,"end":313},"obj":"CL:0009002"}],"text":"We also strongly advocate for utilising clinical samples, obtained as part of appropriate clinical care or for monitoring adverse events following cell administration, to obtain mechanistic information including but not limited to analyses of circulating pro- and anti-inflammatory mediators and inflammatory cell populations."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T490","span":{"begin":147,"end":151},"obj":"Body_part"},{"id":"T491","span":{"begin":309,"end":313},"obj":"Body_part"}],"attributes":[{"id":"A490","pred":"fma_id","subj":"T490","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A491","pred":"fma_id","subj":"T491","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"We also strongly advocate for utilising clinical samples, obtained as part of appropriate clinical care or for monitoring adverse events following cell administration, to obtain mechanistic information including but not limited to analyses of circulating pro- and anti-inflammatory mediators and inflammatory cell populations."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T733","span":{"begin":147,"end":151},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T734","span":{"begin":309,"end":313},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"We also strongly advocate for utilising clinical samples, obtained as part of appropriate clinical care or for monitoring adverse events following cell administration, to obtain mechanistic information including but not limited to analyses of circulating pro- and anti-inflammatory mediators and inflammatory cell populations."}

{"project":"LitCovid-sentences","denotations":[{"id":"T230","span":{"begin":0,"end":326},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We also strongly advocate for utilising clinical samples, obtained as part of appropriate clinical care or for monitoring adverse events following cell administration, to obtain mechanistic information including but not limited to analyses of circulating pro- and anti-inflammatory mediators and inflammatory cell populations."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1438","span":{"begin":40,"end":56},"obj":"Species"},{"id":"1441","span":{"begin":90,"end":98},"obj":"Species"}],"attributes":[{"id":"A1438","pred":"tao:has_database_id","subj":"1438","obj":"Tax:191496"},{"id":"A1441","pred":"tao:has_database_id","subj":"1441","obj":"Tax:191496"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We also strongly advocate for utilising clinical samples, obtained as part of appropriate clinical care or for monitoring adverse events following cell administration, to obtain mechanistic information including but not limited to analyses of circulating pro- and anti-inflammatory mediators and inflammatory cell populations."}